NSF SBIR Phase II
Boston, MA 09/10/2018 – Elektrofi, Inc. has been awarded a Phase II National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $750,000 to conduct research and development (R&D) work on formulating biologics for high concentration, low viscosity subcutaneous administration and the scale up of its system.
About the company: Elektrofi, Inc. is a biotechnology company based in Boston, MA working on drug formulation and ultimately delivery.
Elektrofi has developed a platform which is capable of concentrating biologics by up to 100x and is utilizing this technology to create a paradigm shift from hours-long infusions to seconds-long injections.
About the National Science Foundation’s Small Business Programs: The National Science Foundation (NSF) awards nearly $190 million annually to startups and small businesses through the Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) program, transforming scientific discovery into products and services with commercial and societal impact. The non-dilutive grants support research and development (R&D) across almost all areas of science and technology helping companies de-risk technology for commercial success. The NSF is an independent federal agency with a budget of about $7 billion that supports fundamental research and education across all fields of science and engineering.